BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8101435)

  • 1. Linkage analysis of 7 polymorphic markers at chromosome 11p11.2-11q13 in 27 multiple endocrine neoplasia type 1 families.
    Thakker RV; Wooding C; Pang JT; Farren B; Harding B; Anderson DC; Besser GM; Bouloux P; Brenton DP; Buchanan KD
    Ann Hum Genet; 1993 Jan; 57(1):17-25. PubMed ID: 8101435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic mapping studies of 40 loci and 23 cosmids in chromosome 11p13-11q13, and exclusion of mu-calpain as the multiple endocrine neoplasia type 1 gene.
    Pang JT; Lloyd SE; Wooding C; Farren B; Pottinger B; Harding B; Leigh SE; Pook MA; Benham FJ; Gillett GT; Taggart RT; Thakker RV
    Hum Genet; 1996 Jun; 97(6):732-41. PubMed ID: 8641689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetic mapping of the multiple endocrine neoplasia type 1 locus.
    Pang JT; Pook MA; Eubanks JH; Jones C; van Heyningen V; Evans GA; Thakker RV
    Henry Ford Hosp Med J; 1992; 40(3-4):162-6. PubMed ID: 1362397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linkage analysis of multiple endocrine neoplasia type 1 with INT2 and other markers on chromosome 11.
    Bale SJ; Bale AE; Stewart K; Dachowski L; McBride OW; Glaser T; Green JE; Mulvihill JJ; Brandi ML; Sakaguchi K
    Genomics; 1989 Apr; 4(3):320-2. PubMed ID: 2565877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping eight new polymorphisms in 11q13 in the vicinity of multiple endocrine neoplasia type 1: identification of a new distal recombinant.
    Smith CM; Wells SA; Gerhard DS
    Hum Genet; 1995 Oct; 96(4):377-87. PubMed ID: 7557957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D11S146 and BCL1 are physically linked but can be discriminated by their amplification status in human breast cancer.
    Szepetowski P; Nguyen C; Perucca-Lostanlen D; Carle GF; Tsujimoto Y; Birnbaum D; Theillet C; Gaudray P
    Genomics; 1991 Jun; 10(2):410-6. PubMed ID: 2071147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eighteen new polymorphic markers in the multiple endocrine neoplasia type 1 (MEN1) region.
    Manickam P; Guru SC; Debelenko LV; Agarwal SK; Olufemi SE; Weisemann JM; Boguski MS; Crabtree JS; Wang Y; Roe BA; Lubensky IA; Zhuang Z; Kester MB; Burns AL; Spiegel AM; Marx SJ; Liotta LA; Emmert-Buck MR; Collins FS; Chandrasekharappa SC
    Hum Genet; 1997 Nov; 101(1):102-8. PubMed ID: 9385379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification at chromosome 11q13 in transitional cell tumours of the bladder.
    Proctor AJ; Coombs LM; Cairns JP; Knowles MA
    Oncogene; 1991 May; 6(5):789-95. PubMed ID: 2052357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a 1.2-Mb sequence-ready contig of chromosome 11q13 encompassing the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1.
    Lemmens I; Merregaert J; Van de Ven WJ; Kas K; Zhang CX; Giraud S; Wautot V; Buisson N; De Witte K; Salandre J; Lenoir G; Calender A; Parente F; Quincey D; Courseaux A; Carle GF; Gaudray P; De Wit MJ; Lips CJ; Höppener JW; Khodaei S; Grant AL; Weber G; Kytölä S; Thakker RV
    Genomics; 1997 Aug; 44(1):94-100. PubMed ID: 9286704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exclusion of ZFM1 as a candidate gene for multiple endocrine neoplasia type 1 (MEN1).
    Lloyd SE; Pang JT; Pearce SH; Leigh SE; Thakker RV
    Hum Genet; 1997 May; 99(5):585-9. PubMed ID: 9150722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms.
    Larsson C; Shepherd J; Nakamura Y; Blomberg C; Weber G; Werelius B; Hayward N; Teh B; Tokino T; Seizinger B
    J Clin Invest; 1992 Apr; 89(4):1344-9. PubMed ID: 1348254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors.
    Byström C; Larsson C; Blomberg C; Sandelin K; Falkmer U; Skogseid B; Oberg K; Werner S; Nordenskjöld M
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1968-72. PubMed ID: 1968641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic mapping of the multiple endocrine neoplasia type 1 locus at 11q13.
    Teh BT; Cardinal J; Shepherd J; Hayward NK; Weber G; Cameron D; Larsson C
    J Intern Med; 1995 Sep; 238(3):249-53. PubMed ID: 7673855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and mapping of polymorphic cosmid clones used for sublocalization of the multiple endocrine neoplasia type 1 (MEN1) locus.
    Larsson C; Weber G; Kvanta E; Lewis K; Janson M; Jones C; Glaser T; Evans G; Nordenskjöld M
    Hum Genet; 1992 May; 89(2):187-93. PubMed ID: 1350263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion mapping of endocrine tumors localizes a second tumor suppressor gene on chromosome band 11q13.
    Chakrabarti R; Srivatsan ES; Wood TF; Eubanks PJ; Ebrahimi SA; Gatti RA; Passaro E; Sawicki MP
    Genes Chromosomes Cancer; 1998 Jun; 22(2):130-7. PubMed ID: 9598800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene.
    Debelenko LV; Emmert-Buck MR; Manickam P; Kester M; Guru SC; DiFranco EM; Olufemi SE; Agarwal S; Lubensky IA; Zhuang Z; Burns AL; Spiegel AM; Liotta LA; Collins FS; Marx SJ; Chandrasekharappa SC
    Cancer Res; 1997 Mar; 57(6):1039-42. PubMed ID: 9067266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exclusion of FAU as the multiple endocrine neoplasia type 1 (MEN1) gene.
    Kas K; Weber G; Merregaert J; Michiels L; Sandelin K; Skogseid B; Thompson N; Nordenskjöld M; Larsson C; Friedman E
    Hum Mol Genet; 1993 Apr; 2(4):349-53. PubMed ID: 8099302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 2.8-Mb clone contig of the multiple endocrine neoplasia type 1 (MEN1) region at 11q13.
    Guru SC; Olufemi SE; Manickam P; Cummings C; Gieser LM; Pike BL; Bittner ML; Jiang Y; Chinault AC; Nowak NJ; Brzozowska A; Crabtree JS; Wang Y; Roe BA; Weisemann JM; Boguski MS; Agarwal SK; Burns AL; Spiegel AM; Marx SJ; Flejter WL; de Jong PJ; Collins FS; Chandrasekharappa SC
    Genomics; 1997 Jun; 42(3):436-45. PubMed ID: 9205115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors.
    Debelenko LV; Zhuang Z; Emmert-Buck MR; Chandrasekharappa SC; Manickam P; Guru SC; Marx SJ; Skarulis MC; Spiegel AM; Collins FS; Jensen RT; Liotta LA; Lubensky IA
    Cancer Res; 1997 Jun; 57(11):2238-43. PubMed ID: 9187127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic endocrine tumors with loss of heterozygosity at the multiple endocrine neoplasia type I locus.
    Eubanks PJ; Sawicki MP; Samara GJ; Wan YJ; Gatti RA; Hurwitz M; Passaro E
    Am J Surg; 1997 Jun; 173(6):518-20. PubMed ID: 9207166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.